KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Steris (STE) over the last 8 years, with Q4 2025 value amounting to $101.7 million.

  • Steris' Net Cash Flow rose 194909.09% to $101.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $253.3 million, marking a year-over-year increase of 86828.54%. This contributed to the annual value of -$35.5 million for FY2025, which is 498363.14% down from last year.
  • According to the latest figures from Q4 2025, Steris' Net Cash Flow is $101.7 million, which was up 194909.09% from $40.3 million recorded in Q3 2025.
  • Steris' Net Cash Flow's 5-year high stood at $312.7 million during Q2 2021, with a 5-year trough of -$144.6 million in Q3 2021.
  • Over the past 5 years, Steris' median Net Cash Flow value was -$8.4 million (recorded in 2022), while the average stood at $9.4 million.
  • As far as peak fluctuations go, Steris' Net Cash Flow crashed by 92589.29% in 2024, and later soared by 194909.09% in 2025.
  • Over the past 5 years, Steris' Net Cash Flow (Quarter) stood at -$24.8 million in 2021, then skyrocketed by 46.5% to -$13.2 million in 2022, then plummeted by 93.88% to -$25.7 million in 2023, then skyrocketed by 78.58% to -$5.5 million in 2024, then soared by 1949.09% to $101.7 million in 2025.
  • Its last three reported values are $101.7 million in Q4 2025, $40.3 million for Q3 2025, and $98.4 million during Q2 2025.